Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Medicare Part D reform. 

Opposition to restrictions to six protected classes changes to CMMI Part D Payment Modernization Model in CY 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (86 FR 5864).
MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS ALANNA TEMME (LD, Rep. Jon Porter)
LD, Rep. Jon Porter